NCT04517591

Brief Summary

This research program aims to comprehensively investigate the clinical, physiological, metabolic, and molecular effects of reducing sedentary behavior in post-bariatric patients. To this aim, we will conduct a crossover trial and a randomized controlled trial. The crossover trial aims to unravel potential mechanisms underlying the metabolic, physiological and molecular effects of breaking up sedentary time with light-intensity physical activity versus carrying out the minimum amount of daily exercise at once and then remaining sedentary versus simply remaining sedentary throughout all sessions, in a well-controlled laboratorial condition. The 4-month parallel-group randomized controlled trials aim to investigate the feasibility and efficacy of a newly developed personalized intervention focused on replacing sedentary time with light- (or very light-) intensity physical activity in these patients. A multitude of gold-standard techniques will be applied to evaluate the effects of the intervention on several outcomes, including sedentary time (primary outcome), physical activity levels, clinical parameters specific to each condition, cardiometabolic risk factors, immune function, and health-related quality of life.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2020

Typical duration for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 12, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 18, 2020

Completed
20 days until next milestone

Study Start

First participant enrolled

September 7, 2020

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 8, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 8, 2022

Completed
Last Updated

August 18, 2020

Status Verified

August 1, 2020

Enrollment Period

2.1 years

First QC Date

August 12, 2020

Last Update Submit

August 13, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change from baseline to follow-up on sedentary behaviour

    Sedentary behaviour will be assessed by ActivPAL™

    4 months

Secondary Outcomes (11)

  • Change from baseline to follow-up on physical activity levels

    4 months

  • Change from baseline to follow-up on body composition

    4 months

  • Change from baseline to follow-up on aerobic capacity

    4 months

  • Change from baseline to follow-up on food intake

    4 months

  • Change from baseline to follow-up on office and ambulatory blood pressure

    4 months (RCT) and 5 hours (crossover)

  • +6 more secondary outcomes

Other Outcomes (6)

  • Change from baseline to follow-up on vascular function

    4 months (RCT) and 5 hours (crossover)

  • Change from baseline to follow-up on blood markers

    4 months (RCT) and 5 hours (crossover)

  • Change from baseline to follow-up on inflammatory markers

    4 months

  • +3 more other outcomes

Study Arms (2)

Take a STAND for health

EXPERIMENTAL

A newly developed personalized intervention focused on replacing sedentary time with light-(or very light-) intensity physical activity

Behavioral: The Take a STAND for health

Control

NO INTERVENTION

The control group will receive all regular medical care and advice on healthy lifestyle including the promotion of recommended physical activity levels and health nutrition.

Interventions

A 4-month parallel-group randomised controlled trial will be performed, in which patients post-bariatric surgery will be assessed at baseline pre-surgery (PRE-BAR), 3 months after surgery and pre-intervention (PRE-INT) and 4 months after intervention (POST). Moreover, a sub-sample of patients will perform a randomised crossover trial at baseline (PRE). Patients will complete three experimental sessions in a random manner, as follows: Prolonged sitting (SIT), in which participants engaged in prolonged sitting throughout an 5-h period and were instructed to minimize excessive movement; Exercise followed by prolonged sitting (EX), in which participants performed a 30-min moderate-to-vigorous exercise bout on a treadmill, subsequently, participants engaged in prolonged sitting as described for SIT; Light-intensity breaks (BR), in which participants completed a 3-min bout of light-intensity walking every 30 min of sitting throughout the experimental period.

Take a STAND for health

Eligibility Criteria

Age20 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Obesity, Morbid

Interventions

Health

Condition Hierarchy (Ancestors)

ObesityOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Population Characteristics

Central Study Contacts

Bruno Gualano, Phd

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

August 12, 2020

First Posted

August 18, 2020

Study Start

September 7, 2020

Primary Completion

October 8, 2022

Study Completion

October 8, 2022

Last Updated

August 18, 2020

Record last verified: 2020-08

Data Sharing

IPD Sharing
Will not share